{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:51:08Z","timestamp":1778795468571,"version":"3.51.4"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"abstract":"<jats:p>Dermatomyositis (DM) is an autoimmune disease with no established treatment protocol, often unresponsive to traditional immunosuppressants in severe cases. Anifrolumab blocks dysregulated interferon signalling pathways implicated in DM. We report a challenging case of anti-TIF-1-\u03b3 refractory DM that responded rapidly to anifrolumab, highlighting its potential as a promising treatment option for refractory cutaneous DM.<\/jats:p>","DOI":"10.1093\/ced\/llae476","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:28:42Z","timestamp":1730518122000},"page":"874-876","source":"Crossref","is-referenced-by-count":11,"title":["Anifrolumab use in refractory dermatomyositis: a case report and literature\u00a0review"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8620-3583","authenticated-orcid":false,"given":"Alejandro","family":"Claudio-Oliva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1063-7120","authenticated-orcid":false,"given":"Myriam","family":"Viedma-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Puerta del Mar , Cadiz ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3089-2030","authenticated-orcid":false,"given":"Gonzalo","family":"Gallo-Pineda","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Puerta del Mar , Cadiz ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Prieto-Rozados","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Puerta del Mar , Cadiz ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Villegas-Romero","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Puerta del Mar , Cadiz ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jim\u00e9nez-Gallo","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Puerta del Mar , Cadiz ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Linares-Barrios","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario Puerta del Mar , Cadiz ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"key":"2025032702501285100_llae476-B1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/bjd.15006","article-title":"Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon \u03b2 in dermatomyositis","volume":"176","author":"Huard","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025032702501285100_llae476-B2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jdcr.2023.10.023","article-title":"Refractory dermatomyositis responsive to anifrolumab","volume":"43","author":"Ang","year":"2024","journal-title":"JAAD Case Rep"},{"key":"2025032702501285100_llae476-B3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamadermatol.2023.4744","article-title":"Rapid improvement in recalcitrant cutaneous juvenile dermatomyositis with anifrolumab treatment","volume":"160","author":"Shaw","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025032702501285100_llae476-B4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0961203319885447","article-title":"Type I interferon gene signature test\u2013low and \u2013high patients with systemic lupus erythematosus have distinct gene expression signatures","volume":"28","author":"Brohawn","year":"2019","journal-title":"Lupus"},{"key":"2025032702501285100_llae476-B5","first-page":"256","article-title":"Dermatomyositis: clinicopathological correlations","volume":"153","author":"Sena","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"2025032702501285100_llae476-B6","first-page":"e576","article-title":"Real-life experience of anifrolumab for cutaneous lupus erythematous","volume":"38","author":"Viedma-Mart\u00ednez","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025032702501285100_llae476-B7","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.42526","article-title":"The type I interferon signature reflects multiple phenotypic and activity measures in dermatomyositis","volume":"75","author":"Tabata","year":"2023","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae476\/60298389\/llae476.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/4\/874\/60298389\/llae476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/4\/874\/60298389\/llae476.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:32:31Z","timestamp":1743309151000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/4\/874\/7863454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":7,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,2]]},"published-print":{"date-parts":[[2025,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae476","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,11,2]]}}}